1-1 of 1
Philip Irrgang
Close
Sort by
Journal Articles

Combination of PI3K and PDPK1 Inhibitors Is Highly Effective in Mantle Cell Lymphoma

Grit Hutter, PhD, Yvonne Zimmermann, Anna-Katharina Zoellner, MD, Philip Irrgang, Oliver Weigert, MD, Wolfgang Hiddemann, MD, Martin Dreyling
Journal: Blood
Blood (2014) 124 (21): 3123.
https://doi.org/10.1182/blood.V124.21.3123.3123
Published: 2014